Novotech Featured Reports

41. Hemophilia - Global Clinical Trial Landscape 11/7/2023

    Delve into the clinical landscape of hemophilia, a rare X-linked congenital bleeding disorder, across three key regions of the globe, namely Asia Pacific, Europe, and North America.

42. Primary Biliary Cholangitis – 2023 Global Clinical Trial Landscape 11/7/2023

    See how the development of new drug classes offers the potential for better PBC management, addressing its global impact.

43. The State Of CAR-T Research In China 9/27/2023

    While numerous opportunities are available for companies seeking to undertake CAR-T research in China, understand why embarking on this path requires careful consideration.

44. Exploring Global Clinical Trends In Cell And Gene Therapy 9/15/2023

    Explore the exciting advancements in CNG treatment, such as innovative therapies, ongoing clinical trials, and their potential to positively influence patient outcomes.

45. The Challenges And Opportunities Of Virtual Clinical Trials 9/15/2023

    With ongoing technological advancements, consider several factors as to why experts believe that Virtual Clinical Trials will continue to play a significant role even beyond the post-pandemic era, despite its unique set of challenges.

46. The Future Of Clinical Trials: Embracing Virtualization, RQE, And AI 9/12/2023

    Delve into the swiftly evolving trends that are reshaping the clinical trial industry and examine potential implications for introducing innovative solutions to the market.

47. Going Global: How Working With A CRO Can Benefit Clinical Trials 9/12/2023

    Contract research organizations can be invaluable partners in clinical trials. Dive into the full spectrum of benefits you'll experience by partnering with a globally established and well-resourced CRO.

48. Advantages Of Including Europe And APAC Regions For Clinical Research 9/12/2023

    Discover the advantages of incorporating Europe and APAC regions in clinical trial endeavors, such as accelerated recruitment, streamlined regulatory procedures, access to diverse patient populations, and ultimately, significant cost reductions.

49. Antibody Drug Conjugates And The Global Research Landscape 9/12/2023

    Learn about ADCs advancements in cancer treatment and how the therapy could potentially revolutionize the field by reducing the often severe side effects associated with traditional chemotherapy.

50. Location Considerations For Successful Clinical Trials 9/12/2023

    Consider the advantages associated with conducting early- to late-phase clinical trials in China and the broader APAC region, as well as potential challenges that could impact the trial process and patient outcomes